Insider · CIK 0001727275
William Fairey
Files at KALV (KalVista Pharmaceuticals, Inc.), RNTX (Rein Therapeutics, Inc.), MIRM (Mirum Pharmaceuticals, Inc.). First filing Jun 13, 2025, latest Jun 13, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MIRM: Mirum Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | Mirum Pharmaceuticals, Inc. | $155k 3,203 shares | -56% | +28% from low-9% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | KALV KalVista Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Oct 2, 2025 |
| Jul 23, 2025 | RNTX Rein Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +17,500 | $0.00 | $0 | 17,500 | Jul 23, 2025 |
| Jun 11, 2025 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -3,203 | $48.42 | $155k | 2,500 | Jun 13, 2025 |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock | +5,703 | - | - | 5,703 | Jun 2, 2025 |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -5,703 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +6,268 | $0.00 | $0 | 6,268 | Jun 2, 2025 |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Deferred Stock Unitsderivative | +3,977 | $0.00 | $0 | 3,977 | Jun 2, 2025 |
| Dec 2, 2024 | RNTX Rein Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Dec 6, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.